Bioclinica wants to move the needle in NASH

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 23, 2019 at 10:32 AM.

  1. #1 cafead, Apr 23, 2019 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via One of the big issues is that, being a new area, just how you target this disease and via what biomarkers is still unclear. Bioclinica, a biopharma services company, is launching a new service aimed at using medical imaging in tests designed to push on with trial work in this area.

    article source
     
    Quote

Reply to Thread